Aankondiging • May 06

Long Path Co-Investment Fund 6, LP, Long Path Smaller Companies Master Fund Ltd., Long Path Smaller Companies Fund, LP and Long Path Opportunities Fund Ii, Lp, funds managed by Long Path Partners, LP acquired remaining 85.25% stake in IDOX plc (AIM:IDOX) from group of shareholders.

Long Path Co-Investment Fund 6, LP, Long Path Smaller Companies Master Fund Ltd., Long Path Smaller Companies Fund, LP and Long Path Opportunities Fund Ii, Lp, funds managed by Long Path Partners, LP reached an agreement to acquire remaining 85.25% stake in IDOX plc (AIM:IDOX) from group of shareholders for approximately £290 million on October 28, 2025. A cash consideration valued at £0.715 per share will be paid by Long Path Partners, LP. As part of the acquisition, Long Path Partners, LP along with its funds will acquire through Frankel UK Bidco Limited, a vehicle formed for the purpose of acquisition. Upon completion, Long Path Co-Investment Fund 6, LP will own 87%, Long Path Smaller Companies Master Fund Ltd., and Long Path Smaller Companies Fund, LP will own 7%, and Long Path Opportunities Fund II, LP will own 6% in Bidco. The Acquisition will be implemented by way of a Court-sanctioned scheme of arrangement. The transaction is financed through a combination of equity and debt to be provided under the Interim Facilities Agreement arranged by Guggenheim Partners Europe Limited. Following the Scheme becoming Effective, the Group will continue to be led by the existing management team. It is intended that the non-executive directors of Idox will resign as directors of Idox with effect from the Scheme becoming Effective and be paid in lieu of their contractual notice periods and Idox's head office and certain key functions will continue to be headquartered at the current Idox office. Long Path has no plans to change other locations of Idox. Upon completion, Long Path Partners, LP will own 100% stake in IDOX plc and It is intended that dealings in Idox Shares should be suspended shortly prior to the Effective Date. Since the announcement, IDOX plc has secured additional non-binding letters of intent from shareholders, including Mission Trail Capital Management LLC for 13,830,107 shares, Richard H. Witmer Jr. for 10,003,818 shares, and Mercia Fund Management Limited for 7,528,333 shares. Rathbones reduced its commitment to 32,840,422 shares after selling some shares. This brings the total shares under commitment to 135,033,022, representing 29.25% of Idox's issued share capital. Long Path holds 56,876,997 shares, or 12.32% of the capital. The Idox Directors and Frankel are of the view that the terms of the Acquisition are in the best interests of Idox Shareholders as a whole and therefore, in order to increase the certainty of its execution, Frankel has determined, with the consent of Idox and the Panel, to implement the Acquisition by way of a recommended Takeover Offer, rather than by way of the Scheme. As of January 5, 2026, Frankel received additional binding commitments from certain institutional investors and/or their affiliates and/or related investing vehicles to subscribe for interests, directly or indirectly, in one of the Long Path Funds through which those investors will hold indirect minority interests in Frankel. On 4 January 2026, Long Path Partners, LP received an irrevocable undertaking from Lombard Odier Asset Management (US) Corp to accept or procure acceptance of the Takeover Offer in respect of, in aggregate,18,779,641 Idox Shares. Long Path Partners, LP has also received a non-binding letter of intent from Sand Grove Capital Management LLC to accept the Takeover Offer in aggregate of 26,221,658 Idox Shares. As of January 5, 2026, Frankel determined, with the consent of Idox and the Takeover Panel,to implement the Acquisition by way of a recommended takeover offer, rather than by way of the Scheme. On January 12, 2026, Long Path Partners, LP received a non-binding letter of intent from Trium Capital LLP to accept the Takeover Offer, in respect of 18,459,496 Idox Shares. On January 13, 2026, Long Path Partners, LP received a non-binding letter of intent from BGF Investments LP acting by its manager BGF Investment Management Limited to accept the Takeover Offer, in respect of 7,673,245 Idox Shares. As of January 29, 2026, Frankel received a non-binding letter of intent from Castlebar Capital LLP acting as agent for Castlebar Master Fund Limited to accept the Takeover Offer, in respect of 8,840,572 Idox Shares. Together, through the irrevocable undertakings, non-binding letters of intent and Long Path's shareholding, Frankel has aggregate support for the Acquisition totaling 227,148,326 Idox Shares, representing approximately 49.2%. of the issued share capital of Idox. On February 2026, Frankel may count 117,001,081 Idox Shares, representing approximately 25.34% of Idox's existing issued ordinary share capital, towards satisfaction of the Acceptance Condition. This includes 28,748,136 Idox Shares which are currently held by the SCF Master Fund as referred to below, which, as disclosed in the Offer Document in greater detail, are Rollover Shares and will be transferred to Frankel pursuant to the Transfer Agreement. This includes 28,748,136 Idox Shares which are currently held by the SCF Master Fund as referred to below, which, as disclosed in the Offer Document in greater detail, are Rollover Shares and will be transferred to Frankel pursuant to the Transfer Agreement. As of February 26, 2026 through the irrevocable undertakings, non-binding letters of intent and Long Path's shareholding, Frankel has aggregate support for the Acquisition totaling 258,153,015 Idox Shares, representing approximately 55.92% of the issued share capital of Idox. The transaction is subject to approval of offer by the shareholders of IDOX plc, court approval, Regulatory approvals and Third party clearances. The board of directors of IDOX plc considers the terms to be fair and reasonable and intends to recommend unanimously that the Scheme Shareholders vote in favor of the Scheme at the Court Meeting and that the Idox Shareholders vote in favor of the Resolutions at the General Meeting. The Court Meeting and General meeting is expected to take place on December 15, 2025. As of March 25, 2026, the Chancellor of the Duchy of Lancaster has issued a final notification that no further action in relation to the Acquisition is to be taken under the UK NSI Act. Accordingly, the UK NSI Act Condition has now been satisfied. Frankel and Idox confirm that the French Regulatory Condition remains outstanding. It is expected that the Offer will become or will be declared unconditional in the second quarter of 2026. As of April 16, 2026, the French Ministry of Economy, Finance and Recovery has issued a decision authorizing the completion of the Acquisition. Accordingly, the French Regulatory Condition has also been satisfied. All of the Regulatory Conditions have been satisfied. The Offer remains subject to the Acceptance Condition. As of April 17, 2026, Long Path Partners, LP has received valid acceptances that, when combined with its existing holdings, amount to approximately 42.88% of Idox plc's share capital. This is still below the offer's acceptance condition of acquiring more than 50%. The cash offer of 0.715 per share remains open for acceptance until May 14, 2026. As of April 21, 2026, the Offer has been declared as Unconditional. All remaining Conditions to the Offer have been satisfied or, where applicable, waived. Furthermore, Acceptance Condition has been satisfied. In accordance with the terms of the Offer, withdrawal rights have now ceased to be exercisable. Simon Bridges, Max Hartley, Harry Rees of Canaccord Genuity Limited act as financial advisor for Long Path Partners, LP, Warner Mandel, AntonBlack, Jose Benito Sanz of N.M. Rothschild & Sons Limited act as financial and fairness opinion provider, Neil Patel, BenjaminCryer, Kate Bannatyne, Alice Lane of Peel Hunt LLP act as financial advisor for IDOX plc. Stuart Boyd, Victoria Legg, Khadar Jama, Lloyd Robertson-Jones, Emma Flett, Ben Zeris, Julia Ostendorf, Mavnick Nerwal and Tomás McGrath of Kirkland & Ellis International LLP acted as legal advisor for Long Path Partners, LP. Long Path Co-Investment Fund 6, LP, Long Path Smaller Companies Master Fund Ltd., Long Path Smaller Companies Fund, LP and Long Path Opportunities Fund Ii, Lp, funds managed by Long Path Partners, LP completed the acquisition of remaining 85.25% stake in IDOX plc (AIM:IDOX) from group of shareholders on May 5, 2026. The Offer will initially be open for acceptance until on May 14, 2026.

Software winstgroei	16.0%
Inkomstengroei	7.3%
Toekomstig rendement op eigen vermogen	16.20%
Dekking van analisten	Low
Laatst bijgewerkt	29 May 2026

Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
10/31/2027	104	15	14	26	1
10/31/2026	99	14	12	23	1
10/31/2025	90	6	10	20	N/A
7/31/2025	90	6	12	21	N/A
4/30/2025	89	6	13	22	N/A
1/31/2025	89	6	13	22	N/A
10/31/2024	88	5	12	21	N/A
7/31/2024	84	5	11	20	N/A
4/30/2024	81	5	10	19	N/A
1/31/2024	77	6	10	19	N/A
10/31/2023	73	6	10	19	N/A
7/31/2023	71	6	12	20	N/A
4/30/2023	69	6	14	22	N/A
1/31/2023	67	6	11	19	N/A
10/31/2022	66	6	8	16	N/A
7/31/2022	65	6	N/A	N/A	N/A
4/30/2022	64	6	4	10	N/A
1/31/2022	63	6	7	13	N/A
10/31/2021	62	6	11	17	N/A
7/31/2021	60	5	N/A	N/A	N/A
4/30/2021	58	5	16	23	N/A
1/31/2021	58	3	15	22	N/A
10/31/2020	57	0	14	21	N/A
7/31/2020	61	0	N/A	N/A	N/A
4/30/2020	65	0	12	19	N/A
1/31/2020	65	0	9	16	N/A
10/31/2019	65	-1	6	12	N/A
7/31/2019	66	1	N/A	9	N/A
4/30/2019	66	2	N/A	6	N/A
1/31/2019	66	-13	N/A	8	N/A
10/31/2018	66	-28	N/A	10	N/A
4/30/2018	62	-33	N/A	15	N/A
1/31/2018	68	-16	N/A	14	N/A
10/31/2017	74	2	N/A	13	N/A
7/31/2017	86	5	N/A	12	N/A
4/30/2017	83	9	N/A	9	N/A
1/31/2017	80	10	N/A	10	N/A
10/31/2016	77	12	N/A	11	N/A
7/31/2016	73	12	N/A	11	N/A
4/30/2016	70	12	N/A	12	N/A
1/31/2016	66	10	N/A	10	N/A
10/31/2015	63	8	N/A	8	N/A
7/31/2015	62	7	N/A	8	N/A

Gegevens	Laatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse	2026/05/30 19:28
Aandelenkoers aan het einde van de dag	2026/05/28 00:00
Inkomsten	2025/10/31
Jaarlijkse inkomsten	2025/10/31

Pakket	Gegevens	Tijdframe	Voorbeeld Amerikaanse bron ^*
Financiële gegevens bedrijf	10 jaar	Resultatenrekening Kasstroomoverzicht Balans	SEC-formulier 10-K SEC-formulier 10-Q
Consensus schattingen analisten	+3 jaar	Financiële prognoses Koersdoelen analisten	Onderzoeksrapporten van analisten Blue Matrix
Marktprijzen	30 jaar	Aandelenprijzen Dividenden, splitsingen en acties	ICE Marktgegevens SEC-formulier S-1
Eigendom	10 jaar	Top aandeelhouders Handel met voorkennis	SEC-formulier 4 SEC-formulier 13D
Beheer	10 jaar	Leiderschapsteam Raad van bestuur	SEC-formulier 10-K SEC-formulier DEF 14A
Belangrijkste ontwikkelingen	10 jaar	Bedrijfsaankondigingen	SEC-formulier 8-K

Analist	Instelling
Ciaran Donnelly	Berenberg
Kai Korschelt	Canaccord Genuity
Andrew Murray Darley	Cavendish

This company listing is no longer active

IDOX Toekomstige groei

Future criteriumcontroles 4/6

Belangrijke informatie

Recente toekomstige groei-updates

IDOX plc Provides Earnings Guidance for the Fiscal Year 2025

IDOX plc Provides Earnings Guidance for the Financial Year Ended 31 October 2024

IDOX plc Provides Earnings Guidance for the Year 2024

Consensus EPS estimates fall by 29%, revenue upgraded

Earnings Miss: IDOX plc Missed EPS By 35% And Analysts Are Revising Their Forecasts

IDOX plc Provides Earnings Guidance for the Fiscal Year 2024

Recent updates

Long Path Co-Investment Fund 6, LP, Long Path Smaller Companies Master Fund Ltd., Long Path Smaller Companies Fund, LP and Long Path Opportunities Fund Ii, Lp, funds managed by Long Path Partners, LP acquired remaining 85.25% stake in IDOX plc (AIM:IDOX) from group of shareholders.

Idox PLC Proposes Cancellation of Admission of Shares to Trading on AIM

CEO & Executive Director recently sold UK£2.4m worth of stock

IDOX plc, Annual General Meeting, Mar 31, 2026

Full year 2025 earnings: EPS and revenues miss analyst expectations

IDOX plc Provides Earnings Guidance for the Fiscal Year 2025

First half 2025 earnings released: EPS: UK£0.009 (vs UK£0.007 in 1H 2024)

IDOX plc to Report First Half, 2025 Results on Jun 12, 2025

IDOX plc (AIM:IDOX) acquired Trojan Consultants Limited for £7.9 million from Astuta Ltd.

IDOX plc, Annual General Meeting, Mar 31, 2025

Now 21% overvalued

IDOX plc Appoints Alice Cummings as Senior Independent Director

Dividend increased to UK£0.007

Full year 2024 earnings: EPS misses analyst expectations

Idox plc Proposes Final Dividend for Fiscal Year 2024, Payable on 18 April 2025

IDOX plc to Report Fiscal Year 2024 Results on Jan 28, 2025

IDOX plc Provides Earnings Guidance for the Financial Year Ended 31 October 2024

Less than half of directors are independent

IDOX plc Appoints Jonathan Legdon as Executive Director

IDOX plc Appoints Alex Wrottesley as Director of its Geospatial Division

IDOX plc Appoints Mark Milner as Non-Executive Director

Now 20% overvalued after recent price rise

IDOX plc to Report First Half, 2024 Results on Jun 11, 2024

Now 20% overvalued after recent price rise

IDOX plc Provides Earnings Guidance for the Year 2024

New minor risk - Shareholder dilution

CEO & Executive Director exercised options and sold UK£184k worth of stock

IDOX plc, Annual General Meeting, Mar 28, 2024

Now 22% overvalued after recent price rise

Consensus EPS estimates fall by 29%, revenue upgraded

Earnings Miss: IDOX plc Missed EPS By 35% And Analysts Are Revising Their Forecasts

Dividend increased to UK£0.006

Full year 2023 earnings: EPS and revenues miss analyst expectations

IDOX plc Provides Earnings Guidance for the Fiscal Year 2024

IDOX plc to Report Fiscal Year 2023 Results on Jan 25, 2024

IDOX plc Provides Earnings Guidance for the Fiscal Year 2023

IDOX plc (AIM:IDOX) acquired Emapsite.Com Limited from James Cutler, Masdar (U.K.) Limited, Justin Saunders, Michael Slater, Susan Slater, Richard Pickance, David Warwick and a group of employees for £15.8 million.

First half 2023 earnings released: EPS: UK£0.008 (vs UK£0.007 in 1H 2022)

Price target increased by 10% to UK£0.81

IDOX plc to Report First Half, 2023 Results on Jun 08, 2023

Consensus EPS estimates fall by 10%

Full year 2022 earnings: EPS and revenues miss analyst expectations

IDOX plc to Report Fiscal Year 2022 Results on Jan 26, 2023

Price target decreased to UK£0.74

Price target decreased to UK£0.74

First half 2022 earnings released

Full year 2021 earnings: EPS and revenues exceed analyst expectations

High number of new directors

New 90-day high: UK£0.55

Full year 2020 earnings released: EPS UK£0.003 (vs UK£0.003 loss in FY 2019)

Earnings beat expectations, revenue disappoints

IDOX (LON:IDOX) Seems To Use Debt Quite Sensibly

Returns On Capital At IDOX (LON:IDOX) Paint An Interesting Picture

New 90-day high: UK£0.54

Calculating The Intrinsic Value Of IDOX plc (LON:IDOX)

The IDOX (LON:IDOX) Share Price Has Gained 46% And Shareholders Are Hoping For More

New 90-day high: UK£0.50

New 90-day low: UK£0.46

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven

Bedrijfsanalyse en status van financiële gegevens

Gegevensbronnen

Analysemodel en Snowflake

Industrie en sector

Bronnen van analisten